Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis

Background: Matrix metalloproteinase-9 (MMP-9) is a novel marker of intestinal inflammation. The aim of this study was to assess if serum MMP-9 levels predict clinical flare in patients with quiescent Crohn’s disease (CD). Methods: This study was a post hoc analysis of a prospective observational st...

Full description

Bibliographic Details
Main Authors: Doron Yablecovitch, Uri Kopylov, Adi Lahat, Michal M. Amitai, Eyal Klang, Dana Ben-Ami Shor, Sandra Neuman, Nina Levhar, Ella Fudim, Benjamin Avidan, Ido Laish, Limor Selinger, Noam Zingboim-Orbach, Orit Picard, Miri Yavzori, Rami Eliakim, Shomron Ben-Horin
Format: Article
Language:English
Published: SAGE Publishing 2019-10-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284819881590

Internet

https://doi.org/10.1177/1756284819881590

Similar Items